Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to FR7431276ApriorityCriticalpatent/FR2284332A1/fr
Publication of FR2284332A1publicationCriticalpatent/FR2284332A1/fr
Application grantedgrantedCritical
Publication of FR2284332B1publicationCriticalpatent/FR2284332B1/fr
Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside.
Reactieprodukten en esters van polyolen met tenminste 3 hydroxylgroepen en melkzuur, depotmatrixmateriaal en parenteraal farmaceutisch depot preparaat.
Empirical 13C-NMR-correlations between the Escherichia coli K 13 and LP 1092 capsular polysaccharides and model oligosaccharides containing d-ribose and 3-deoxy-d-manno-2-octulosonic acid
Enterally highly-absorbable preparations of cardiac glycosides which by themselves are absorbable with difficulty, and process forthe production of such preparations